A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision Model

BACKGROUND: Although hepatitis B infection is the major cause of chronic liver disease in Iran, no studies have employed economic evaluations of the medications used to treat Iranian patients with chronic hepatitis B (CHB). Therefore, the cost-effectiveness of the different treatment options for thi...

詳細記述

保存先:
書誌詳細
出版年:Hepat Mon
主要な著者: Keshavarz, Khosro, Kebriaeezadeh, Abbas, Alavian, Seyed Moayed, Akbari Sari, Ali, Rezaei Hemami, Mohsen, Lotfi, Farhad, Hashemi Meshkini, Amir, Javanbakht, Mehdi, Keshvari, Maryam, Nikfar, Shekoufeh
フォーマット: Artigo
言語:Inglês
出版事項: Kowsar 2016
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5091008/
https://ncbi.nlm.nih.gov/pubmed/27822262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.37435
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料